Regional research offices
Chuck Howard - Patient story
Julie Randall - Patient story
Tara Foote - Provider story
If you have questions about clinical trials or want help finding the right one for you, contact our:
Patient Engagement Center Phone: 844-552-2734
This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.
Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.
The purpose of this world-wide prospective parallel-cohort study in patients with relapsing forms of MS, either newly treated with fingolimod or...
This study will evaluate relaxin (RLX) levels in patients with multiple sclerosis. Key Eligibilities: -Females 18 to 45 years of age.-Patients with...
FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) target the relapsing phase of MS but have minimal impact once the...
The purpose of this study is to evaluate the safety and efficacy of elezanumab in subjects with relapsing Multiple Sclerosis (RMS).Key Inclusion...
Inclusion Criteria:-Aged 18-60 years-Meets 2017 McDonald criteria for relapsing-remitting MS [patients with clinically isolated syndrome (CIS) are...